Hu Caihui,Chen Jingyu,Zheng Chenpeng,et al.Clinical outcomes of microwave ablation under ultrasonic guidance for benign thyroid nodules in children[J].Journal of Clinical Pediatric Surgery,2024,(03):262-266.[doi:10.3760/cma.j.cn101785-202306027-012]
超声引导下微波消融治疗儿童甲状腺结节的临床疗效分析
- Title:
- Clinical outcomes of microwave ablation under ultrasonic guidance for benign thyroid nodules in children
- Keywords:
- Benign Thyroid Nodules; Microwave Ablation; Thyroid Hormones; Surgical Procedures; Operative; Child
- 摘要:
- 目的 初步探讨超声引导下经皮穿刺微波消融治疗儿童甲状腺良性结节的安全性、临床疗效。 方法 回顾性分析2022年1月至2022年12月在重庆医科大学附属儿童医院接受超声引导下微波消融治疗的9例甲状腺良性结节患儿临床资料。观察指标包括手术情况(切口大小、总手术时长、消融时长、术中出血量及是否输血等)、疼痛评分、甲状腺功能及超声相关指标。医师根据FACES(Wong-Baker pain rating scale)脸谱疼痛法评估患儿一般情况,术后采用超声造影评估消融率,常规超声随访结节体积变化以评估疗效,并记录术中、术后的不良反应及并发症。 结果 9例患儿(共14个结节)总手术时长为(45.11±4.85)min(23~65 min),消融时长为(188.89±50.37)s(40~500 s),术中出血量为(0.3±0.03)mL(0.1~0.4 mL)。患儿术后12 h FACES评分为2~4分,术后24 h FACES评分为0~2分。术后即刻超声造影结果显示,14个结节消融率均为100%。术前结节体积为0.73(0.14,3.62)cm3,术后1个月结节体积为0.54(0.19,1.49)cm3,术后4个月结节体积为0.03(0.02,0.25)cm3;术后4个月结节体积较术前显著减小(H=12.714,P=0.018),较术后1个月显著减小(H=12.036,P=0.028)。术前血清游离三碘甲状腺原氨酸 (free triiodothyronine, FT3)为(6.44±1.42)Pmol/L(4.43~8.2 Pmol/L),术后12 h为(12.8±3.37)Pmol/L(8.36~18.5 Pmol/L),术后1个月为(7.54±1.56)Pmol/L(5.36~9.53 Pmol/L);术后12 h较术前显著增高,差异有统计学意义(F=19.636,P＜0.001)。不同时点的血清游离甲状腺素 (free thyroxine, FT4)、促甲状腺激素(thyrotropin,thyroid stimulating hormone,TSH)差异均无统计学意义 (P>0.05)。术中无一例出血过多等不良反应,术后无一例声音嘶哑、抽搐、饮水呛咳等并发症。 结论 超声引导下微波消融术可能是治疗儿童甲状腺良性结节的一种新选择,具有微创、安全性高、临床疗效好、对甲状腺功能损伤小、疼痛感弱等优势;然而本研究样本量相对较小,仍需大样本研究来进一步验证本研究结果。
- Abstract:
- Objective To explore the safety,clinical efficacies and outcomes of ultrasound-guided percutaneous microwave ablation for children with benign thyroid nodules.Methods A retrospective analysis was conducted for the clinical data of 9 children with benign thyroid nodules undergoing ultrasound-guided percutaneous microwave ablation from January 2022 to December 2022.The relevant parameters included general surgical profiles (incision size,total operative duration,ablation duration,intraoperative volume of blood loss & necessity for blood transfusion),pain scores,thyroid function and ultrasound-related parameters.Results In 9/14 nodules,overall operative duration was (45.11±4.85)(23-65) min,ablation time (188.89±50.37)(40-500) sec and intraoperative volume of hemorrhage (0.3±0.03)(0.1-0.4) mL.The postoperative Wong-Baker pain rating scale (FACES) scores were (2-4)/(0-2) points at 12/24 h.Immediate postoperative contrast-enhanced ultrasonography confirmed the ablation rate of all 14 nodules was 100%.The median nodule volume was 0.73(0.14,3.62)cm3 before operation,0.54(0.15,1.49)cm3 at 1 month after opeation,0.03(0.02,0.25)cm3 at 4 months after operation,The nodule volume at 4 months after operation was significantly smaller than that before operation(H=12.174,P=0.018) and 1 month after operation(H=12.036,P=0.028)The serum FT3 was (6.44±1.42)(4.43-8.2) Pmol/L pre-operation,(12.8±3.37)(8.36-18.5) Pmol/L at 12 h post-operation,(7.54±1.56)(5.36-9.53) Pmol/L at Month 1 post-operation.Serum FT3 was significantly higher at 12 h post-operation than pre-operation (F=19.636,P<0.001).No statistically significant differences existed in serum levels of FT4 and TSH at various timepoints (P>0.05).Neither adverse reactions nor postoperative complications occurred.Conclusions Ultrasound-guided percutaneous microwave ablation is ideal benign thyroid nodules in children.It offers such advantages as mini-invasiveness,high safety,satisfactory outcomes,minimal damage to thyroid function and minimal pains.However,the study’s limited sample size necessitates further large-scale trials for validating the findings.
参考文献/References:
[1] Bauer AJ.Thyroid nodules in children and adolescents[J].Curr Opin Endocrinol Diabetes Obes,2019,26(5):266-274.DOI:10.1097/MED.0000000000000495.
[2] 国家儿童医学中心,国家儿童肿瘤监测中心,中华医学会小儿外科学分会,等.中国儿童甲状腺结节及分化型甲状腺癌专家共识[J].中华实用儿科临床杂志,2020,35(20):1521-1530.DOI:10.3760/cma.j.cn101070-20200804-01291.National Center for Children’s Health,National Children’s Cancer Surveillance Center,Branch of Pediatric Surgery,Chinese Medical Association,et al.Expert Consensus on Thyroid Nodules and Differentiated Thyroid Cancer for Chinese Children[J].Chin J Appl Clin Pediatr,2020,35(20):1521-1530.DOI:10.3760/cma.j.cn101070-20200804-01291.
[3] Bukarica S,Anti? J,Fratri? I,et al.Thyroid surgery in children:a 5-year retrospective study at a single paediatric surgical center and systematic review[J].Children (Basel),2022,9(12):1818.DOI:10.3390/children9121818.
[4] Goldfarb M,Dinauer C.Differences in the management of thyroid nodules in children and adolescents as compared to adults[J].Curr Opin Endocrinol Diabetes Obes,2022,29(5):466-473.DOI:10.1097/MED.0000000000000754.
[5] Ignjatovi? M,Cuk V,Ozegovi? A,et al.Early complications in surgical treatment of thyroid diseases:analysis of 2100 patients[J].Acta Chir Iugosl,2003,50(3):155-175.
[6] Cheng ZG,Liang P.Advances in ultrasound-guided thermal ablation for symptomatic benign thyroid nodules[J].Adv Clin Exp Med,2020,29(9):1123-1129.DOI:10.17219/acem/125433.
[7] Divarc? E,?eltik ü,D?kümcü Z,et al.Management of childhood thyroid nodules:surgical and endocrinological findings in a large group of cases[J].J Clin Res Pediatr Endocrinol,2017,9(3):222-228.DOI:10.4274/jcrpe.4272.
[8] Lee KA,Sharabiani MTA,Tumino D,et al.Differentiated thyroid cancer in children:a UK multicentre review and review of the literature[J].Clin Oncol (R Coll Radiol),2019,31(6):385-390.DOI:10.1016/j.clon.2019.02.005.
[9] Christison-Lagay ER,Baertschiger RM,Dinauer C,et al.Pediatric differentiated thyroid carcinoma:an update from the APSA Cancer Committee[J].J Pediatr Surg,2020,55(11):2273-2283.DOI:10.1016/j.jpedsurg.2020.05.003.
[10] Du JR,Li WH,Quan CH,et al.Long-term outcome of microwave ablation for benign thyroid nodules:over 48-month follow-up study[J].Front Endocrinol (Lausanne),2022,13:941137.DOI:10.3389/fendo.2022.941137.
[11] Li LW,Qiu XG.Safety and efficacy of ultrasound-guided radiofrequency ablation for benign nonfunctional thyroid nodules in children:a retrospective study of 62 patients with over four years of follow-up[J].Thyroid,2022,32(5):525-535.DOI:10.1089/thy.2021.0454.
[12] 石文媛,陈佳佳,张潇,等.超声引导经皮微波消融治疗儿童难治性甲状腺功能亢进症1例[J].中华超声影像学杂志,2022,31(8):730-732.DOI:10.3760/cma.j.cn131148-20220530-00390.Shi WY,Chen JJ,Zhang X,et al.Ultrasound-guided percutaneous microwave ablation for refractory hyperthyroidism in children:one case report[J].Chin J Ultrasonogr,2022,31(8):730-732.DOI:10.3760/cma.j.cn131148-20220530-00390.
[13] 李宇靖,杨小敏,徐志坚.甲状腺结节消融术研究进展[J].中国中西医结合耳鼻咽喉科杂志,2021,29(4):318-320,307.DOI:10.16542/j.cnki.issn.1007-4856.2021.04.021.Li YJ,Yang XM,Xu ZJ.Research advances of thyroid nodule ablation[J].Chin J Otorhinolaryngol Integr Med,2021,29(4):318-320,307.DOI:10.16542/j.cnki.issn.1007-4856.2021.04.021.
[14] 孙永强,杨雯雯,郑帅,等.微波消融治疗甲状腺良性结节短期、中期临床效果观察及影响因素分析[J].中国临床医生杂志,2019,47(9):1064-1067.DOI:10.3969/j.issn.2095-8552.2019.09.019.Sun YQ,Yang WW,Zheng S,et al.Observation of short/medium-term clinical effects and analysis of influencing factors of microwave ablation for benign thyroid nodules[J].Chin J Clin,2019,47(9):1064-1067.DOI:10.3969/j.issn.2095-8552.2019.09.019.
[15] 任云,王圣应,黄广岩,等.微波消融治疗甲状腺良性结节的疗效及预后影响因素分析[J].宁夏医科大学学报,2021,43(3):277-281.DOI:10.16050/j.cnki.issn1674-6309.2021.03.014.Ren Y,Wang SY,Huang GY,et al.Outcomes and prognostic factors of microwave ablation for benign thyroid nodule[J].J Ningxia Med Univ,2021,43(3):277-281.DOI:10.16050/j.cnki.issn1674-6309.2021.03.014.
[16] 李柯伶,马亦龙.甲状腺良性结节微波消融和手术切除临床疗效和安全性对比分析[J].中国介入影像与治疗学,2017,14(8):464-467.DOI:10.13929/j.1672-8475.201703035.Li KL,Ma YL.Comparative study of clinical efficacy and safety of microwave ablation and surgical resection of benign thyroid nodules[J].Chin J Interv Imaging Ther,2017,14(8):464-467.DOI:10.13929/j.1672-8475.201703035.
备注/Memo
收稿日期:2023-6-15。
通讯作者:孔祥如,Email:Kongru873@163.com